Report Categories
View AllRecent Articles
View All
AKTS Aktis reports quarterly results amid clinical pipeline progress investors await strategic update on oncology trials
SWK Stanley Q3 2000 earnings narrowly miss estimates shares dip 072 percent on soft yearoveryear revenue
AI DisruptionDriven CrossSector Equity Volatility
YUMC Yum China posts Q4 2025 double digit earnings beat and 44 percent revenue growth as shares edge higher
Is Cue Biopharma CUE stock rejecting resistance Skyrockets 20260420